|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Underwood SM, Ramsay-Johnson E, Browne L,
Caines N, Dean A, Duval S, Ivalis R, Lawrence ND, Lewis N, Mulkanen
M, et al: What women in the United States Virgin Islands still want
and need to know about HPV, cervical cancer, and condom use. J Natl
Black Nurses Assoc. 21:25–32. 2010.PubMed/NCBI
|
|
3
|
Malagón T, Kulasingam S, Mayrand MH,
Ogilvie G, Smith L, Bouchard C, Gotlieb W and Franco EL: Age at
last screening and remaining lifetime risk of cervical cancer in
older, unvaccinated, HPV-negative women: A modelling study. Lancet
Oncol. 19:1569–1578. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoevel T, Macek R, Swisshelm K and Kubbies
M: Reexpression of the TJ protein CLDN1 induces apoptosis in breast
tumor spheroids. Int J Cancer. 108:374–383. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bjurberg M, Beskow C, Kannisto P and
Lindahl G: Cervical cancer is a clinical challenge. Lakartidningen.
112:2015.(In Swedish). PubMed/NCBI
|
|
6
|
Hu Z and Ma D: The precision prevention
and therapy of HPV-related cervical cancer: New concepts and
clinical implications. Cancer Med. 7:5217–5236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang J, Zhang H and Jin S: Epigenetics and
cervical cancer: From pathogenesis to therapy. Tumour Biol.
35:5083–5093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goodman A: HPV testing as a screen for
cervical cancer. BMJ. 350:h23722015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chrysostomou AC, Stylianou DC,
Constantinidou A and Kostrikis LG: Cervical cancer screening
programs in Europe: The transition towards HPV vaccination and
population-based HPV testing. Viruses. 10:7292018. View Article : Google Scholar
|
|
10
|
Vu M, Yu J, Awolude OA and Chuang L:
Cervical cancer worldwide. Curr Probl Cancer. 42:457–465. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wuerthner BA and Avila-Wallace M: Cervical
cancer: Screening, management, and prevention. Nurse Pract.
41:18–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mountzios G, Soultati A, Pectasides D,
Pectasides E, Dimopoulos MA and Papadimitriou CA: Developments in
the systemic treatment of metastatic cervical cancer. Cancer Treat
Rev. 39:430–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zihni C, Mills C, Matter K and Balda MS:
Tight junctions: From simple barriers to multifunctional molecular
gates. Nat Rev Mol Cell Biol. 17:564–580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsukita S, Tanaka H and Tamura A: The
claudins: From tight junctions to biological systems. Trends
Biochem Sci. 44:141–152. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki T: Regulation of intestinal
epithelial permeability by tight junctions. Cell Mol Life Sci.
70:631–659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sawada N: Tight junction-related human
diseases. Pathol Int. 63:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Campbell HK, Maiers JL and DeMali KA:
Interplay between tight junctions & adherens junctions. Exp
Cell Res. 358:39–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amarnath S and Agarwala S:
Cell-cycle-dependent TGFβ-BMP antagonism regulates neural tube
closure by modulating tight junctions. J Cell Sci. 130:119–131.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Adegoke EO, Ma M, Huang F, Zhang
H, Adeniran SO, Zheng P and Zhang G: Influence of Wilms' tumor
suppressor gene WT1 on bovine Sertoli cells polarity and tight
junctions via non-canonical WNT signaling pathway. Theriogenology.
138:84–93. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ruch TR and Engel JN: Targeting the
mucosal barrier: How pathogens modulate the cellular polarity
network. Cold Spring Harb Perspect Biol. 9:a0279532017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X, Ahmad US, Huang Y, Uttagomol J,
Rehman A, Zhou K, Warnes G, McArthur S, Parkinson EK and Wan H:
Desmoglein-3 acts as a pro-survival protein by suppressing reactive
oxygen species and doming whilst augmenting the tight junctions in
MDCK cells. Mech Ageing Dev. 184:1111742019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsugami Y, Matsunaga K, Suzuki T,
Nishimura T and Kobayashi K: Phytoestrogens weaken the blood-milk
barrier in lactating mammary epithelial cells by affecting tight
junctions and cell viability. J Agric Food Chem. 65:11118–11124.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Pascalis C and Etienne-Manneville S:
Single and collective cell migration: The mechanics of adhesions.
Mol Biol Cell. 28:1833–1846. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Calder MD, Edwards NA, Betts DH and Watson
AJ: Treatment with AICAR inhibits blastocyst development,
trophectoderm differentiation and tight junction formation and
function in mice. Mol Hum Reprod. 23:771–785. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ryu WI, Lee H, Bae HC, Jeon J, Ryu HJ, Kim
J, Kim JH, Son JW, Kim J, Imai Y, et al: IL-33 down-regulates CLDN1
expression through the ERK/STAT3 pathway in keratinocytes. J
Dermatol Sci. 90:313–322. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baktash Y, Madhav A, Coller KE and Randall
G: Single particle imaging of polarized hepatoma organoids upon
hepatitis C virus infection reveals an ordered and sequential entry
process. Cell Host Microbe. 23:382–394.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Jiang F, Jia X, Lan J, Guo H, Li E,
Yan A and Wang Y: Cycling hypoxia affects cell invasion and
proliferation through direct regulation of claudin1/claudin7
expression, and indirect regulation of P18 through claudin7.
Oncotarget. 8:10298–10311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhat AA, Syed N, Therachiyil L, Nisar S,
Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S,
Al-Naemi H, et al: Claudin-1, a double-edged sword in cancer. Int J
Mol Sci. 21:5692020. View Article : Google Scholar
|
|
30
|
Dehghan Esmatabadi MJ, Farhangi B, Safari
Z, Kazerooni H, Shirzad H, Zolghadr F and Sadeghizadeh M:
Dendrosomal curcumin inhibits metastatic potential of human SW480
colon cancer cells through Down-regulation of Claudin1, Zeb1 and
Hef1-1 gene expression. Asian Pac J Cancer Prev. 16:2473–2481.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eftang LL, Esbensen Y, Tannæs TM, Blom GP,
Bukholm IR and Bukholm G: Up-regulation of CLDN1 in gastric cancer
is correlated with reduced survival. BMC Cancer. 13:5862013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu J, Gao F, Xu T, Li J, Hu Z, Wang C,
Long Y, He X, Deng X, Ren D, et al: CLDN1 induces autophagy to
promote proliferation and metastasis of esophageal squamous
carcinoma through AMPK/STAT1/ULK1 signaling. J Cell Physiol.
235:2245–2259. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chao YC, Pan SH, Yang SC, Yu SL, Che TF,
Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, et al: Claudin-1 is a
metastasis suppressor and correlates with clinical outcome in lung
adenocarcinoma. Am J Respir Crit Care Med. 179:123–133. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sheehan GM, Kallakury BV, Sheehan CE,
Fisher HA, Kaufman RP Jr and Ross JS: Loss of claudins-1 and −7 and
expression of claudins-3 and −4 correlate with prognostic variables
in prostatic adenocarcinomas. Hum Pathol. 38:564–569. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Emmanouilidi A, Paladin D, Greening DW and
Falasca M: Oncogenic and non-malignant pancreatic exosome cargo
reveal distinct expression of oncogenic and prognostic factors
involved in tumor invasion and metastasis. Proteomics.
19:e18001582019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun BS, Yao YQ, Pei BX, Zhang ZF and Wang
CL: Claudin-1 correlates with poor prognosis in lung
adenocarcinoma. Thorac Cancer. 7:556–563. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mahati S, Xiao L, Yang Y, Mao R and Bao Y:
miR-29a suppresses growth and migration of hepatocellular carcinoma
by regulating CLDN1. Biochem Biophys Res Commun. 486:732–737. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hoellen F, Waldmann A, Banz-Jansen C,
Holtrich U, Karn T, Oberländer M, Habermann JK, Hörmann M, Köster
F, Ribbat-Idel J, et al: Claudin-1 expression in cervical cancer.
Mol Clin Oncol. 7:880–884. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang WN, Li W, Wang XL, Hu Z, Zhu D, Ding
WC, Liu D, Li KZ, Ma D and Wang H: CLDN1 expression in cervical
cancer cells is related to tumor invasion and metastasis.
Oncotarget. 7:87449–87461. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cunniffe C, Brankin B, Lambkin H and Ryan
F: The role of claudin-1 and claudin-7 in cervical tumorigenesis.
Anticancer Res. 34:2851–2857. 2014.PubMed/NCBI
|
|
41
|
Zhou Y, Liu H, Wang J, Wang X, Qian L, Xu
F, Song W, Wu D, Shen Z, Feng D, et al: ΔNp63α exerts antitumor
functions in cervical squamous cell carcinoma. Oncogene.
39:905–921. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Soares E and Zhou H: Master regulatory
role of p63 in epidermal development and disease. Cell Mol Life
Sci. 75:1179–1190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hsiao YH, Hsieh MJ, Yang SF, Chen SP, Tsai
WC and Chen PN: Phloretin suppresses metastasis by targeting
protease and inhibits cancer stemness and angiogenesis in human
cervical cancer cells. Phytomedicine. 62:1529642019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kuo KT, Chen CL, Chou TY, Yeh CT, Lee WH
and Wang LS: Nm23H1 mediates tumor invasion in esophageal squamous
cell carcinoma by regulation of CLDN1 through the AKT signaling.
Oncogenesis. 5:e2392016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liebner S, Fischmann A, Rascher G, Duffner
F, Grote EH, Kalbacher H and Wolburg H: Claudin-1 and claudin-5
expression and tight junction morphology are altered in blood
vessels of human glioblastoma multiforme. Acta Neuropathol.
100:323–331. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hammer SC, Nagel S, Junginger J,
Hewicker-Trautwein M, Wagner S, Heisterkamp A, Ngezahayo A, Nolte I
and Murua Escobar H: Claudin-1, −3, −4 and −7 gene expression
analyses in canine prostate carcinoma and mammary tissue derived
cell lines. Neoplasma. 63:231–238. 2016.PubMed/NCBI
|
|
48
|
Feng S, Zhai J, Lu D, Lin J, Dong X, Liu
X, Wu H, Roden AC, Brandi G, Tavolari S, et al: TUSC3 accelerates
cancer growth and induces epithelial-mesenchymal transition by
upregulating claudin-1 in non-small-cell lung cancer cells. Exp
Cell Res. 373:44–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Upmanyu N, Bulldan A, Papadopoulos D,
Dietze R, Malviya VN and Scheiner-Bobis G: Impairment of the
Gnα11-controlled expression of claudin-1 and MMP-9 and collective
migration of human breast cancer MCF-7 cells by DHEAS. J Steroid
Biochem Mol Biol. 182:50–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Torres-Martínez AC, Gallardo-Vera JF,
Lara-Holguin AN, Montaño LF and Rendón-Huerta EP: Claudin-6
enhances cell invasiveness through claudin-1 in AGS human
adenocarcinoma gastric cancer cells. Exp Cell Res. 350:226–235.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Youssefian L, Vahidnezhad H, Saeidian AH,
Sotoudeh S, Zeinali S and Uitto J: Gene-targeted next-generation
sequencing identifies a novel CLDN1 mutation in a consanguineous
family with NISCH syndrome. Am J Gastroenterol. 112:396–398. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hu A, Li J, Ruan S, Fan Y and Liao Y:
Polymorphisms in CLDN1 are associated with age and differentiation
of triple-negative breast cancer patients. Biosci Rep.
39:BSR201819522019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tokés AM, Kulka J, Paku S, Szik A, Páska
C, Novák PK, Szilák L, Kiss A, Bögi K and Schaff Z: Claudin-1, −3
and −4 proteins and mRNA expression in benign and malignant breast
lesions: A research study. Breast Cancer Res. 7:R296–R305. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou B, Blanchard A, Wang N, Ma X, Han J,
Schroedter I, Leygue E and Myal Y: Claudin 1 promotes migration and
increases sensitivity to tamoxifen and anticancer drugs in
luminal-like human breast cancer cells MCF7. Cancer Inves.
33:429–439. 2015. View Article : Google Scholar
|
|
55
|
Chen Yh, Lu Q, Schneeberger EE and
Goodenough DA: Restoration of tight junction structure and barrier
function by down-regulation of the mitogen-activated protein kinase
pathway in ras-transformed Madin-Darby canine kidney cells. Mol
Biol Cell. 11:849–862. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lippoldt A, Liebner S, Andbjer B,
Kalbacher H, Wolburg H, Haller H and Fuxe K: Organization of
choroid plexus epithelial and endothelial cell tight junctions and
regulation of claudin-1, −2 and −5 expression by protein kinase C.
Neuroreport. 11:1427–1431. 2000. View Article : Google Scholar : PubMed/NCBI
|
